会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明公开
    • Novel antagonists of platelet activating factor
    • 血小板减少症
    • EP0336142A2
    • 1989-10-11
    • EP89104429.9
    • 1989-03-13
    • AMERICAN CYANAMID COMPANY
    • Wissner, AllanSchaub, Robert E.Sum, Phaik-Eng
    • C07F9/12C07C149/46C07F9/54C07F9/65A61K31/66A61K31/095C07D215/10C07D521/00C07D213/20C07D277/22C07F9/58C07F9/62
    • C07D213/20C07C43/1745C07C43/1785C07C59/125C07C309/73C07D215/10C07D231/12C07D233/56C07D249/08C07D277/22C07F9/12C07F9/581C07F9/60C07F9/62C07F9/650911C07F9/650958C07F9/6539
    • The invention is a compound of R or S enantiomers or racemic mixtures of compounds of the formula:
      wherein:

      (A) X is

      (i) C 1 -C 24
      (ii) C 1 -C 24 alkoxy;
      (iii) C 1 -C 24 carboamoyloxy;


      or
      wherein n is an integer from 1 to 25 and m is an integer from 0 to 24 and the sum of n and m is less than or equal to 25;
      (v) phenyl;
      (vi) mono- or polysubstituted phenyl substituted with C 1 -C 20 alkyl, C 1 -C 20 alkoxy, halogen, trifluoromethyl, phenyl, substituted phenyl or benzyloxy;
      (vii) phenoxy;
      (viii) mono- or polysubstituted phenoxy substituted with C 1 -C 20 alkyl, Ci-C 2 o alkoxy, halogen, trifluoromethyl, phenyl substituted phenyl or benzyloxy;
      (ix) naphthaloxy;
      (x) mono- or polysubstituted naphthaloxy substituted with C 1 -C 20 alkyl, C 1 -C 20 alkoxy or halogen;
      (xi) -O-(CH 2 ) r -O-((CH 2 ) p O) t -(CH 2 ) a -W wherein W is methyl or phenyl optionally substituted with C,-C 3 alkyl, C 1 -C 3 alkoxy or phenyl, r, p, t and a are integers such that the expression r + (p + 1)t + a is also an integer and has a value of 3 to 20; r is greater than or equal to 2; p is greater than or equal to 2; t is greater than or equal to zero; and a is greater than or equal to zero;

      (B) i is an integer from 1 to 3 and j is an integer from 1 to 6;
      (C) Q is -OR 2 ,


      or O-C-R 2 , wherein R 2 is hydrogen, C 1 -C 6 alkyl or C 1 -C 6 alkenyl; (D) Y is a divalent radical

      or


      (E) the moiety R 3 represents one or more C 1 -C 5 alkyl, C 1 -C 5 alkoxy or halogen substituents of the aromatic ring;
      (F) the moiety -CH 2 A may be in the ortho, meta or para position wherein A is

      (i) a 5-7 member aromatic heterocyclic ring containing at least one nitrogen and one or more nitrogen or sulfur atoms:
      (ii)
      or
      (iii)
      which are PAF inhibitors.
    • 本发明是下式化合物的R或S对映异构体或外消旋混合物的化合物:其中:(A)X为(ⅰ)C 1 -C 24(ⅱ)C 1 -C 24烷氧基; (iii)C 1 -C 24甲酰氧基; (iiii)其中n为1至25的整数,m为0至24的整数,n和m的和小于或等于25; (v)苯基; (vi)被C 1 -C 20烷基,C 1 -C 20烷氧基,卤素,三氟甲基,苯基,取代的苯基或苄氧基取代的单取代或多取代的苯基; (vii)苯氧基; (viii)被C 1 -C 20烷基,C 1 -C 20烷氧基,卤素,三氟甲基,苯基取代的苯基或苄氧基取代的单或多取代的苯氧基; (ix)萘氧基; (x)被C 1 -C 20烷基,C 1 -C 20烷氧基或卤素取代的单取代或多取代的萘​​氧基; (Xi)-O-(CH2)rO - ((CH2)pO)t-(CH2)aW其中W是甲基或任选被C 1 -C 3烷基,C 1 -C 3烷氧基或苯基,R,p,t和 a是整数,使得表达式r +(p + 1)t + a也是整数,并且具有3至20的值; r大于或等于2; p大于或等于2; t大于或等于零; a大于或等于零; (B)i为1〜3的整数,j为1〜6的整数, (C)Q为-OR2,或O-C-R2,其中R2为氢,C1-C6烷基或C1-C6烯基; (D)Y是二价基团-O - , - OCH2-或CHEM(E)部分R 3表示芳环的一个或多个C 1 -C 5烷基,C 1 -C 5烷氧基或卤素取代基; (F)部分-CH 2 A可以在邻位,间位或对位,其中A是(i)含有至少一个氮和一个或多个氮或硫原子的5-7元芳族杂环:(ii)(iii)作为PAF抑制剂的。 2